Ex-Merck scientist views on Vioxx changed
The former top scientist at Merck testified Monday that he initially concluded an internal study of Vioxx linked the drug to an increase in heart attacks and strokes less than a year after it was approved for sale.
More…
Mixed Verdicts for Merck in Vioxx Cases
A New Jersey jury ruled that Merck failed to provide adequate warning about the risks of its Vioxx painkiller in one of two cases decided.
More...
Texas Vioxx verdict reduced
Merck & Co. failed to persuade a Texas judge to throw out an April jury verdict in a product- liability lawsuit against the company about its Vioxx painkiller.
Click here for more info
Merck Wins 2nd Vioxx Lawsuit
THURSDAY, Nov. 3 (HealthDay News) -- In the second case of its kind, a New Jersey jury on Thursday agreed with drug maker Merck & Co. that a 60-year-old man's heart attack was not triggered by use of the company's now-banned painkiller Vioxx.
More...